The Translational PET Imaging lab is applying in vivo molecular imaging techniques, e.g. Positron Emission Tomography (PET), for advancement of our understanding and management of different pathologies, in particular metabolic disease and cancer.
Our current main research interests are development and validation of non-invasive imaging methodologies for assessment of immune cells, fibrotic processes and pancreatic beta cells, as well as assisting drug development, by design of novel imaging-based endpoints (e.g. in vivo mode of action, drug biodistribution).
Bibliometric data January 2020: >85 publications, h-index = 25.